| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 264.77M | 361.26M | 315.14M | 213.66M | 279.02M |
| Gross Profit | 18.98M | 31.25M | 34.40M | 32.54M | 6.83M |
| EBITDA | 22.34M | 38.88M | 42.96M | 34.15M | 1.73M |
| Net Income | -9.65M | 4.29M | 10.84M | 11.19M | -14.47M |
Balance Sheet | |||||
| Total Assets | 276.72M | 356.32M | 311.89M | 288.30M | 275.69M |
| Cash, Cash Equivalents and Short-Term Investments | 13.11M | 17.31M | 29.11M | 14.34M | 21.78M |
| Total Debt | 69.48M | 114.43M | 97.28M | 76.44M | 32.63M |
| Total Liabilities | 104.99M | 174.93M | 134.79M | 122.04M | 120.63M |
| Stockholders Equity | 171.73M | 181.38M | 177.10M | 166.26M | 155.07M |
Cash Flow | |||||
| Free Cash Flow | 44.62M | -14.23M | -9.60M | -53.90M | -20.31M |
| Operating Cash Flow | 71.53M | -4.26M | 37.18M | -21.85M | 9.03M |
| Investing Cash Flow | -23.45M | -12.00M | -35.52M | -20.76M | -18.29M |
| Financing Cash Flow | -52.27M | 4.46M | 13.10M | 35.17M | 8.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$2.20B | 3.90 | 16.17% | 12.15% | -3.66% | 4.32% | |
73 Outperform | HK$1.18B | 17.58 | 5.24% | 13.24% | -13.83% | 50.41% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$1.26B | 1,251.38 | -0.11% | ― | -2.02% | -101.97% | |
54 Neutral | HK$253.36M | 78.17 | -5.72% | ― | -16.89% | -1700.00% | |
49 Neutral | HK$650.36M | -0.30 | -118.41% | ― | -3.72% | 21.15% | |
46 Neutral | HK$328.54M | 2.01 | -6.00% | 7.35% | 24.69% | -257.79% |